TOT BIOPHARM International Co Ltd - ESG Rating & Company Profile powered by AI
This assessment of TOT BIOPHARM International Co Ltd incorporates information from across the internet as well as from public disclosures by TOT BIOPHARM International Co Ltd. The SDG assessment for TOT BIOPHARM International Co Ltd indicates its transparency towards the UN SDGs. Check the bottom of the webpage for potential risks for TOT BIOPHARM International Co Ltd based on industry, location and marketcap.
TOT BIOPHARM International Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | TOT BIOPHARM International Co Ltd | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does TOT BIOPHARM International Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd offer flexible work?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose water use targets?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid TOT BIOPHARM International Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas TOT BIOPHARM International Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs TOT BIOPHARM International Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose its waste policy?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose energy use targets?
Sign up for free to unlockDoes TOT BIOPHARM International Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes TOT BIOPHARM International Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for TOT BIOPHARM International Co Ltd
These potential risks are based on the size, segment and geographies of the company.
TOT BIOPHARM International Company Limited, an investment holding company, engages in the research and development, manufacture, and marketing of anti-tumor drugs in the People's Republic of China. The company's principal drug candidate is TAB008 for the treatment of non-squamous non-small-cell lung cancer metastatic colorectal cancer, glioblastoma multiforme, ovarian cancer, cervical cancer, and hepatocellular carcinoma. It also offers TOZ309 for malignant brain tumor. Further, the company develops TAA013 for HER2+ breast cancer which is under Phase III clinical trial; TAE020 which is under preclinical trial for acute myeloid leukemia; TAB014 for wet age-related macular degeneration and is under Phase II clinical trial. In addition, it develops TAY018 for non-Hodgkin's lymphoma, myelodysplastic syndrome, acute myelogenous leukemia, and solid tumors; TAC020 for various solid tumors; TEP118 for biliary cancer, gallbladder tumors, metastatic cancer, non-small-cell lung cancer (NSCLC), and gastric cancer; TOM312 for cancer and HIV-associated cachexia; TIC318 for epithelial-derived ovarian cancer, small-cell lung cancer, head and neck squamous cell carcinoma, testicular tumors, malignant lymphoma, cervical cancer, bladder cancer, and NSCLC; TVP211 and TID214 for solid tumors; and TIO217 for gastrointestinal tumors. TOT BIOPHARM International Company Limited was incorporated in 2009 and is headquartered in Suzhou, the People's Republic of China.